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Abstract 
A PCR-RFLP method was used to identify cry2A toxin genes in a collection of 300 strains of Bacillus 
thuringiensis. From 81 genes identified, the vast majority appeared to be cry2Aa or cry2Ab, however 
three showed a different pattern and were subsequently cloned and sequenced. The gene cloned from 
strain HD395 was named cry2Ba2. Since the proteins encoded by the genes cloned from LS5115-3 
and DS415 shared >95% sequence identity with existing toxins their genes were named cry2Aa17 and 
cry2Ab29 respectively by the toxin nomenclature committee. Despite this overall similarity these two 
toxins resembled natural hybrids, with Cry2Ab29 resembling Cry2Ab for the majority of the protein 
but then showing identity to Cry2Aa for the last 66 amino acids. For Cry2Aa17, Domains II and III 
most closely resembled Cry2Aa (99% identity) whilst Domain I was identical to that of Cry2Ab. The 
toxicity of the recombinant toxins was tested against Aedes aegypti and Spodoptera exigua, and it was 
found that the toxicity profile of Cry2Aa17 more closely matched the profile of Cry2Ab than that of 
Cry2Aa, thus implicating Domain I in specificity determination. This association of Domain I with 
toxicity was confirmed when hybrids were made between Cry2Aa and Cry2Ab. 
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1. Introduction 
Bacillus thuringiensis (Bt) is a gram positive bacterial species that produces insecticidal toxins during 
sporulation (Raymond et al., 2010). These toxins are encoded by plasmid-borne cry genes, which have 
been incorporated into transgenic crops to provide insect-resistant properties (Pardo-Lopez et al., 
2013). Currently over 300 different Cry toxins have been sequenced and named, and the Cry toxins 
have been classified into 74 primary families (Cry1 to Cry74) based solely on their amino acid identity 
(Crickmore et al., 1998). Amongst these the Cry2 toxins are an interesting family with 12 subgroups 
(Cry2Aa-Cry2Ak, Cry2Ba) of which some have dual activity against lepidopteran and dipteran larvae 
(van Frankenhuyzen, 2013). Since Donovan et al. isolated the first cry2 gene (Donovan et al., 1988) 
over 70 cry2A toxin genes have now been cloned (Crickmore et al., 2017). Competition binding assays 
have shown that Cry2A binding sites on the guts of commercially relevant Heliothine species are 
different from those of Cry1 and Vip3A, supporting the practice of combining Cry2A with Cry1 and 
Vip3A in transgenic crops to delay the onset of resistance (Gouffon et al., 2011; Hernandez-Rodriguez 
et al., 2008). 
PCR based methods have proved an efficient way to identify Bt toxin genes (Ben-Dov et al., 
1997). In particular, PCR-RFLP has been applied widely in cry gene identification and is capable of 
identifying variants of existing genes (Kuo and Chak, 1996; Patel and Ingle, 2012). In the current 
investigation, we used PCR-RFLP to identify and characterize cry2 genes in a collection of 300 Bt 
strains. 
 
2. Materials and methods 
2.1 Bacterial strains and plasmids 
Ninety six of the B. thuringiensis strains used in this study were purchased from the Bacillus Genetic 
Stock Center (BGSC). The rest were native strains isolated from Shaanxi and stored in our laboratory. 
Escherichia coli DH5α was used for common transformations whilst Rosetta (DE3) was used for the 
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expressing the cloned genes.  
2.2 PCR-RFLP 
B. thuringiensis strains were incubated overnight at 30°C on Luria-Bertani (LB) agar plates.Genomic 
DNA was extracted and purified as described previously (Shu et al., 2013a). A 50 μl PCR mixture was 
composed of 1 μl (10ng) of template DNA, 25 μl Premix Taq Version 2.0 (TaKara), 0.2 μmol l-1 of 
primers Cry2-FL and Cry2-RL (Table 1), and 22 μl ultrapure water. PCR was carried out for 30 cycles 
(at 940C for 1 min, 550C for 1 min, and 720C for 2.5 min) with a 2 min pre-denaturation stage at 940C 
and a final elongation stage of 7 mins at 720C. PCR products were digested with both Hinf I and Sau3A 
I enzymes in a 30 μl digestion mixture composed of: 10 μl of PCR product, 3 μl 10 x reaction buffer, 
15 μl ultrapure water and 1 μl (1U) of each enzyme (TaKara). Digestion was carried out at 37 0C for 2 
hours before the restriction fragments were separated on a 2% agarose gel. 
2.3 Cloning and expression of cry2 genes 
Purified PCR products were cloned into the Ecl136II site of pEB (Shu et al., 2016) and then introduced 
into E. coli DH5α. A 5’ primer from pEB (TCATAACGTCCCGCGAAAT) and the 3’ primer (Cry2-
RL) were used to screen transformants for plasmids containing cry2 genes in the correct orientation 
for expression. The hybrid toxins were created by amplifying Domain I using primers DIF and DIR 
(Table 1) and ligating this to the acceptor plasmid in which the entire plasmid, except Domain I, had 
been amplified using primers DIIF and PlasmidR. To express the Cry2 proteins, E.coli Rosetta (DE3) 
was transformed with the appropriate plasmid and grown in LB medium containing ampicillin (100 
mg l-1) overnight. The culture was then diluted (1:100) into fresh LB medium (1000 ml) containing 
ampicillin and incubated with shaking (370C, 230 rpm) until an OD600 of 0.6–0.8 was reached after 
which isopropyl-β-d-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 mmol l-
1. Cultures were maintained with shaking (200C, 12 h, 130 rpm) then centrifuged (10 000 g, 12 min, 
40C). The culture supernatant was discarded, and the pellet suspended in 70 ml 20 mM Tris-HCl (pH 
8.0). The suspended cells were sonicated (medium-intensity pulses, 6 min) centrifuged again (10000 
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g, 15 min, 40C) and both pellet and soluble fractions collected. The pellet was resuspended in 2 ml of 
the same buffer (20 mM Tris-HCl, pH8.0) and stored at –200C. After sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS–PAGE), an estimation of Cry2 protein concentration was 
made by densitometry using bovine serum albumin (BSA) as a standard.  
2.4 Insecticidal bioassays 
For Aedes aegypti twenty late 3rd instar larvae and Cry2 inclusions were added to 80ml of deionized 
water and incubated at 270C with a 18 light: 6 hour dark photoperiod. A small amount of larval food 
(ground TetraMin fish food) was also added to each beaker. The number of dead larvae was counted 
after a period of 72 hours. Larvae incapable of rising to the surface of the water, or not showing the 
characteristic diving reaction when the water was disturbed, were counted as dead. If more than 10% 
of the control larvae pupated, or if more than 20% mortality was recorded in the control, then the test 
was discarded and repeated. 
Insecticidal activity against first-instar larvae of S. exigua was measured by incorporating the 
resuspended Cry2 inclusions into an artificial diet (Jiang et al., 1999). Each concentration was tested 
with 24 insects and survival was recorded after 7 days. All bioassays were replicated at least three 
times. 
2.5 Nucleotide sequence accession numbers 
The nucleotide sequence data for cry2Ab29, cry2Aa17 and cry2Ba2 were assigned GenBank accession 
numbers KF860847, KF860848 and KF014123 respectively. 
 
3 Results 
3.1 Cloning and characterization of the cry2 genes 
Based on conserved regions around the start and stop codons of the cry2A genes a pair of universal 
primers (Cry2-FL, Cry2-RL) was designed (Table 1). Analysis of the gene sequences indicated that 
digestion of the amplified gene sequence with Hinf I and Sau3A I could distinguish between the cry2 
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variants (Table 1). 300 strains were screened of which 81 gave a positive PCR signal and RFLP analysis 
of the PCR products gave five distinct patterns. Two of these patterns corresponded to those predicted 
for cry2Aa and cry2Ab, whereas the other three appeared unique (Fig 1). Of the 81 amplicons tested 
32 gave the cry2Aa pattern and 46 the cry2Ab pattern, the three unique patterns were each identified 
in only one strain. The three amplicons giving these unique patterns were cloned and sequenced. The 
deduced amino acid sequence from the gene cloned from HD395 was 99% identical to the Cry2Ba1 
toxin and so the gene was named cry2Ba2. The polypeptide encoded by the gene from SD415 was 98% 
identical with Cry2Ab1 and so its gene was named cry2Ab29. Interestingly all 10 of the amino acid 
differences between Cry2Ab1 and Cry2Ab29 are found in the last 66 amino acids and Cry2Ab29 only 
differs from Cry2Aa1 by 1 amino acid in this region. This suggests that Cry2Ab29 is a natural hybrid 
of Cry2Ab and Cry2Aa. A similar phenomenon was found with the gene cloned from LD5115-3, the 
first 278 amino acids of the encoded toxin (which corresponds to Domain I and the first two beta-
strands of Domain II) matched Cry2Ab1 exactly, whereas the final 355 matched Cry2Aa. The overall 
sequence identity of the protein was close enough to Cry2Aa for the toxin to be named Cry2Aa17, but 
it also appears to be a Cry2Aa/Cry2Ab hybrid. 
3.2 Domain analysis 
Since native Cry2A toxins that appeared to be hybrids of previously identified Cry2A toxins had been 
identified, an analysis of other publicly available Cry2A sequences was undertaken to look for other 
putative hybrids. Fig 2 shows the clustering patterns of individual domains of these Cry2A proteins 
and shows a number of toxins (highlighted by boxes) where a particular domain of that toxin does not 
cluster with other toxins sharing the same tertiary classification. For example, as noted above, domain 
I of Cry2Aa17 clusters with the Cry2Ab toxins not the Cry2Aa ones. Of the 10 different tertiary ranks 
analyzed (Cry2Aa-Cry2Ak) there are eight different Domain I sequences identified along with ten 
different Domain IIs and seven Domain IIIs. As well as the Cry2Aa17 and Cry2Ab29 hybrids described 
in this study, eight other natural hybrids were identified (Fig 3).  
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3.3 Expression of the toxins. 
The toxins encoded by the three genes with the variant RFLP patterns were expressed alongside control 
toxins Cry2Aa (AAO13750), Cry2Ab (AAO13296) and Cry2Ah (EU939453). All six were expressed 
at a high level and accumulated predominantly in the insoluble fraction (Fig 4), as is common for 
recombinant crystal proteins expressed in E. coli (Agaisse and Lereclus, 1995). 
3.4 Insecticidal activity 
Since it is well established in the literature that Cry2Aa is toxic to Aedes aegypti whereas Cry2Ab is 
not (van Frankenhuyzen, 2013) we tested these two new hybrids for activity against this mosquito. 
Using a discriminatory dose of 2µg/ml we confirmed that Cry2Aa was toxic (>50% mortality) while 
Cry2Ab and Cry2Ah were non-toxic (<10% mortality), however none of three new toxins showed any 
activity. Since previous work had indicated that a region in Domain II between amino acids 278 and 
340 was responsible for determining toxicity towards A. aegypti (Liang and Dean, 1994; Widner and 
Whiteley, 1990) it was unexpected that Cry2Aa17 was non-toxic given that it was identical to Cry2Aa1 
from amino acid 279 onwards. To test whether Cry2Aa17 was functional as a toxin a bioassay was 
performed on S. exigua where a dose of 100µg/ml was found to be toxic (>40% mortality) confirming 
that there were no major functional defects in this toxin. This result implied that residues in the first 
278 amino acids could influence specificity against A. aegypti. However since there were two amino 
acids downstream of this point in Cry2Aa17 that matched Cry2Ab1 and not Cry2Aa1 we eliminated 
the possibility that these could be influencing specificity by creating a mutated form (mCry2Aa17) 
that contained the mutations E451A and P630S. Using the same concentrations as above mCry2Aa17 
was found to retain activity against S. exigua but remained inactive against A. aegypti. To test whether 
the differences between Cry2Aa17/Cry2Ab29 and their “type” toxins could affect their activity against 
S. exigua bioassays were performed against this insect. The data (Fig 5) indicate that Cry2Ab and 
Cry2Ah are more toxic than Cry2Aa and that Cry2Aa17 more closely resembles Cry2Ab. Cry2Ab29 
had a similar level of toxicity to Cry2Ab, while Cry2Ba2 had no obvious activity. These results are 
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consistent with the observation that regions within the first 278 amino acids can influence specificity.  
3.5 Creation of Cry2Aa/Cry2Ab hybrids 
To test the possibility that Domain I could influence the specificity of Cry2A toxins against A. aegypti 
hybrids were created in which this domain (amino acids 1-263) was exchanged between Cry2Aa and 
Cry2Ab. The two resulting hybrids (Cry2AaAbAb and Cry2AbAaAa) were expressed and tested 
against A. aegypti. The former was found to be toxic (>50% mortality at 2µg/ml) while the latter had 
no detectable activity. This result again confirms a potential role of Domain I in determining the 
specificity of the Cry2A toxins. 
 
4 Discussion 
The PCR-RFLP screen used in this study to identify cry2 genes within Bt strains identified two genes 
that appeared to encode hybrid toxins. It is known that genetic exchange can take place between Cry 
toxin genes and that this can affect specificity, indeed such recombination in vivo helps explain the 
large diversity of Bt toxins found in nature (de Maagd et al., 2001). Earlier studies on the Cry2A 
toxins noted that whilst Cry2Aa had activity against both the Lepidopteran Manduca sexta and the 
Dipteran Aedes aegypti, Cry2Ab, despite sharing 87% sequence identity with Cry2Aa, had no 
activity against A. aegypti (Widner and Whiteley, 1989). The same authors later went on to create 
hybrids between Cry2Aa and Cry2Ab which identified putative blocks, both within Domain II, 
responsible for activity against each order of insect (Widner and Whiteley, 1990). Liang and Dean 
later used naturally occurring restriction sites that split Domain II into 3 approximately equal parts 
and created a number of hybrids (Liang and Dean, 1994). This work indicated that the specificity 
regions were not co-linear and that whilst part 1 was enough to confer specificity to another 
lepidopteran insect (Lymantria dispar) activity against A. aegypti required both parts 1 and 2.  
When the structure of Cry2Aa was solved (Morse et al., 2001), the authors identified a putative 
binding epitope in the regions identified in the above hybrid studies. It was later established that 
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although Cry2Ab does not have activity against A. aegypti it is toxic to another species of mosquito, 
Anopheles gambiae (McNeil and Dean, 2011). Amino acids in the putative specificity region that 
differed between Cry2Aa and Cry2Ab were individually exchanged, in Cry2Ab, and although some 
mutants lost activity to A. gambiae none gained activity to A. aegypti. 
The data that we obtained on Cry2Ah adds to that previously published (Shu et al., 2013b) and 
extends its spectrum of activity to S. exigua. An interesting observation from our data is that the 
toxins that have good activity against S. exigua (Cry2Ab, Cry2Ah, mCry2Aa17 and Cry2Ab29) have 
weak or no activity against A. aegypti whereas Cry2Aa which is highly active to the mosquito is only 
weakly active against S. exigua. If this association holds for other Cry2A toxins it could help unravel 
the mechanisms behind specificity determination. 
Most work on the mechanism of action of Bt toxins has concentrated on the roles of Domains II and 
III in binding to the target cells and whilst mutations in Domain I are known to affect toxicity there is 
no evidence that this domain plays a role in specificity determination (Bravo et al., 2013). Whilst our 
data indicate an association between Domain I and specificity the mechanism is unclear. It is 
conceivable that some of the steps involving Domain I, such as toxin stability, oligomerization or 
pore-formation are executed differently in different insects and thus can affect relative toxicity. 
Differences in Domain I may result in structural changes in the other two domains and thus indirectly 
affect toxin binding, alternatively the region of Domain I previously hypothesized to be masking the 
A. aegypti receptor-binding surface (Morse et al., 2001) may actually be contributing directly to that 
specific binding. 
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Table 1 Primers and PCR-RFLP data 
Gene or 
primer 
Accession no. 
Sequence 
Product 
size (bp) 
Fragment sizes (bp) with  
Hinf Ι and Sau3A Ι 
cry2-FL 
cry2-RL 
DIF 
DIR 
DIIF 
PlasmidR 
 ATGAATAGTGTATTGAATAGCGG 
TTAATAAAGTGGTGAAAGATTAGTTGG 
ATGAATAATGTATTGAATAAYGGAAG 
TTTAAATAACGACCAGATRGAKACATA 
TATCAAAGCCTTCTAGTATCTTCYG 
ATAAAATTCCTCCTTAATCGAATTC 
  
cry2Aa1 AAA22335  1902 597,340,290,140,122,113, 
cry2Ab1 AAA22342  1902 832,290,263,112,105, 
cry2Ac1 CAA40536  1902 499,338,282,244,185,112, 
cry2Ad1 AAF09583  1902 985,290,263,112, 
cry2Ae1 AAQ52362  1902 654,341,280,254, 
cry2Af1 ABO30519  1902 429,363,290,138,112,107, 
cry2Ag1 ACH91610  1902 522,418,290,263,112, 
cry2Ah1 EU939453  1902 829,338,263,112,105, 
cry2Ai1 FJ788388  1902 340,290,244,185,168,140,122,113 
cry2Ba2 KF014123  1875 532, 341, 308, 180, 140, 130, 112,  
cry2Aa1
Ⅰ
 KF860848  1902 832, 290, 140, 122, 113, 105 
cry2Ab29 KF860847  1902 832, 290, 263, 112, 105, 
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Figure 1. PCR-RFLP patterns of amplified cry2 genes. 
 
 
Figure 2 Clustering relationships between individual domains of Cry2 toxins 
Relationships were inferred using the Neighbor-Joining method (Saitou and Nei, 1987). The optimal 
tree with the sum of branch length = 0.80606492 is shown. The percentage of replicate trees in which 
the associated taxa clustered together in the bootstrap test (500 replicates) is shown next to the branches 
(Felsenstein, 1985). The tree is drawn to scale, with branch lengths in the same units as those of the 
distances used to infer the phylogenetic tree. The evolutionary distances were computed using the 
Poisson correction method (Zuckerkandl and Pauling, 1965) and are in the units of the number of 
amino acid substitutions per site. The analysis involved 72 amino acid sequences. All positions 
containing gaps and missing data were eliminated. Evolutionary analyses were conducted in MEGA5 
(Tamura et al., 2011).  
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Figure 3. Domain configurations of the Cry2A toxins. 
Each toxin is split into the three domains identified from crystallographic studies of Cry2Aa (Morse 
et al., 2001). Domains of the same color are those that cluster together at a distance of <0.02 as 
shown in Fig 2. 
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Figure 4. SDS-PAGE analysis of recombinant Cry2A toxins 
I: insoluble fraction; S: soluble fraction. pEB is a control sample of E. coli Rosetta harboring just the 
expression vector pEB. 
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Figure 5. Toxicity of the Cry2A toxins towards Spodoptera exigua. 
First instar larvae were exposed to a dose of 100µg/ml of toxin and mortality assessed after 7 days. 
The data represent an average of three replicates and the bars indicate one standard error of the mean. 
 
